Skip to contentSkip to filters

We use cookies for analytics.

Grant, Call number PAR-25-183

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

National Institutes of Health

Related content

About

Test a pharmacological or neuromodulation intervention for a mental disorder in an early clinical trial. The R33 supports experimental therapeutics studies that measure clinical effects alongside evidence about the mechanism of the intervention.

Topics

Eligibility

Covers: The R33 funds early-stage clinical testing.

Eligible organizations based outside the US may apply.

simpler.grants.govgrants.nih.gov

Eligible organizations include universities, nonprofit research organizations and other categories specified in the announcement. Eligible organizations based outside the US may apply.

Source: simpler.grants.gov